Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
about
Neuronal Nav1.8 Channels as a Novel Therapeutic Target of Acute Atrial Fibrillation Prevention.Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.Molecular mechanisms of atrial fibrosis: implications for the clinic.Improving Atrial Fibrillation Therapy: Is There a Gene for That?Calcium Signaling and Cardiac Arrhythmias.Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype.Angiotensin II affects inflammation mechanisms via AMPK-related signalling pathways in HL-1 atrial myocytes.The More Effective Treatment of Atrial Fibrillation Applying the Natural Compounds; as NADPH Oxidase and Ion Channel Inhibitors.In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding.MicroRNA-208a-3p contributes to connexin40 remolding in human chronic atrial fibrillation.Dysfunction of Myosin Light-Chain 4 (MYL4) Leads to Heritable Atrial Cardiomyopathy With Electrical, Contractile, and Structural Components: Evidence From Genetically-Engineered Rats.Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?Association Between Peripheral Artery Disease and Incident Risk of Atrial Fibrillation: Strong Evidence Coming From Population-Based Cohort Studies.The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation.The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial Fibrillation.Activin Receptor-Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological HypertrophyAtrial Fibrillation Mechanisms and Implications for Catheter Ablation
P2860
Q37556202-7CE229D6-84D8-477B-8498-3ABE3B53F343Q38677229-2310F642-6E4B-45BC-9F7A-D976056CDD0BQ38749008-45F89334-5138-45CF-9162-DB92114EF87DQ38828102-17A64CB2-F1F0-45C1-92DB-8FE827E522EFQ39360546-D1E2CE20-2977-4312-92D3-8093898D8E5AQ41570348-739965A7-2F60-410A-B8B1-6770202E711EQ41606804-D9CF8274-3A6D-4947-8168-BA68FDC84E45Q41934785-4F803D22-C64A-4DE8-8F15-B3CCC371E600Q46015261-8D75E23E-ECE5-44DF-B756-2E462DEE028BQ47098772-CBA91B25-B3D7-440C-A237-BCDC9701947FQ47146472-B5CB32EE-E20F-4CAD-908F-5E2DA53160D0Q48540569-A181BE07-A248-4A8B-89EA-EFA22178BD0BQ54233839-3CBDD98F-2045-4B5D-AD45-2A257F9922FAQ54998714-3E39CF9D-C6F2-4717-B395-BEE155146637Q55554939-30CC20BE-4355-4B6E-8A9C-78AEB93BD17DQ58129769-A7C5745D-41D4-4A41-8907-32596D40EE24Q59136309-171C4332-416A-4975-B878-33B4C90D6640
P2860
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
@en
type
label
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
@en
prefLabel
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
@en
P1476
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.
@en
P2093
Dobromir Dobrev
P304
P356
10.1038/NRCARDIO.2016.118
P407
P577
2016-08-04T00:00:00Z